A Short Review on Animal Models in Psychopharmacology
Abstract
Psychopharmacological disorders are among the leading cause of non-fatal disease burden in India. One in seven Indians was affected by psychopharmacological disorders. Although psychopharmacological agents is used for the management of psychological disorders like anxiety, psychosis, depression and mania it may side effects such as tardative dyskinesia, weight gain, weight loss, muscle cramps, dysphoria, gastrointestinal upset, eye problems or problems with blood tests. In this present review we made an exposure regarding many screening methods on evaluation of psychopharmacological disorders like anxiety, depression, psychosis and mania in the aspects of preclinical studies. These methods are very useful to evaluate the psychopharmacological agents like anti-anxiety agents, anti-psychotics, anti-depressants and anti-manic agents.
Read the paper
Related studies
- A Coupled SYSTEM of Intracellular Ca 2+ Clocks and Surface Membrane Voltage Clocks Controls the Timekeeping Mechanism of the Heart’s Pacemaker
- A Comprehensive Review on the Therapeutic Potential of Curcuma longa Linn. in Relation to its Major Active Constituent Curcumin
- Cancer epigenetics: Moving forward
- Current developments in LC-MS for pharmaceutical analysis
- Myricetin: A comprehensive review on its biological potentials
- A Computational Systems Biology Software Platform for Multiscale Modeling and Simulation: Integrating Whole-Body Physiology, Disease Biology, and Molecular Reaction Networks
Go deeper in Evidence Hub
Evidence Hub adds a study data sheet (design, sample size, evidence level, key numbers), an AI summary and a chat grounded in the paper's text.